Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2323]

Novel strategy could help overcome resistance to radiotherapy in metastatic...

Dr Marie Dutreix – Institut Curie, Orsay, France

Novel strategy could help overcome resistance to radiotherapy in metastatic melanoma ( Dr Marie Dutreix – Institut Curie, Orsay, France )

Interim WINTHER study findings provide lessons for future research

Prof Jean-Charles Soria – Institut Gustave Roussy, Villejuif, France

Interim WINTHER study findings provide lessons for future research ( Prof Jean-Charles Soria – Institut Gustave Roussy, Villejuif, France )

WIN Symposium 2015 highlights

Prof Richard Schilsky - Chief Medical Officer of the American Society of...

WIN Symposium 2015 highlights ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )

Next generation of trials with targeted agents

Prof Richard Schilsky - Chief Medical Officer of the American Society of...

Next generation of trials with targeted agents ( Prof Richard Schilsky - Chief Medical Officer of the American Society of Oncology (ASCO) )

Meta-analysis confirms benefits and safety of precision medicine

Prof Razelle Kurzrock - University of California, San Diego, USA

Meta-analysis confirms benefits and safety of precision medicine ( Prof Razelle Kurzrock - University of California, San Diego, USA )

SPRING – rolling tri-therapy combinations of targeted drugs in second line of...

Prof Razelle Kurzrock - University of California, San Diego, USA

SPRING – rolling tri-therapy combinations of targeted drugs in second line of metastatic NSCLC ( Prof Razelle Kurzrock - University of California, San Diego, USA )

TAT 2016: Targeted anticancer therapies

Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA

TAT 2016: Targeted anticancer therapies ( Dr Giuseppe Giaccone - Georgetown University Medical Center, Washington, USA )

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma

Dr Jessica Okosun - Barts Cancer Institute, London, UK

Recurrent mTORC1-activating RRAGC mutations in follicular lymphoma ( Dr Jessica Okosun - Barts Cancer Institute, London, UK )

Exciting new developments in proton therapy treatments

Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain

Exciting new developments in proton therapy treatments ( Dr Hernán Cortés-Funes - HC Marbella, Marbella, Spain )

EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM

Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia

EHA 2015: Reviewing the treatment landscapes of CLL, MCL, and MM ( Prof John Gribben, Prof Marivi Mateos, Prof Umberto Vitolo, Prof Paolo Ghia )

Overview of innovation in Hodgkin's lymphoma

Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award

Overview of innovation in Hodgkin's lymphoma ( Prof Volker Diehl - Winner of the Jean Bernard Lifetime Achievement Award )

EHA 2015: Expert opinions on new treatment standard in multiple myeloma

Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry...

EHA 2015: Expert opinions on new treatment standard in multiple myeloma ( Prof Pieter Sonneveld, Prof Antonio Palumbo, Prof Gordon McVie, Prof Thierry Facon )

More from ecancer